<p>EC Healthcare has reported its interim results for the six months ended 30 September 2025. The group recorded revenue of HKD 1.9 billion, reflecting a 6.4% decrease year-on-year. Sales volume amounted to HKD 1.9 billion, down 7.0% compared to the same period last year. EBITDA margin for the period stood at 8.9%, while net profit margin was 0.2%. Profit before tax reached HKD 14.3 million. The company declared no interim dividend for the period. As of 30 September 2025, EC Healthcare’s gearing ratio was 38.8%, with outstanding interest-bearing bank borrowings of HKD 605.6 million and convertible bonds of HKD 254.3 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EC Healthcare published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11964699), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

02138

<p>EC Healthcare reported a significant drop in its half-year net profit by 89.5% to HKD 4.2 million for the six months ended 30 September 2025. Revenue decreased by 6.4% year-on-year to HKD 1.9 billion. The company declared no interim dividend and had a gearing ratio of 38.8%.</p>

EC Healthcare half-year net profit drops 89.5% to HKD 4.2 million